Skip to main content

Advertisement

SpringerLink
Log in

Quality of Life After Radiotherapy for Rectal and Anal Cancer

  • Radiation Therapy and Radiation Therapy Innovations in Colorectal Cancer (P Lee and A Raldow, Section Editors)
  • Published:
Current Colorectal Cancer Reports

Abstract

Purpose of Review

With advances in radiation therapy (RT) techniques for rectal and anal cancers allowing for the modulation of critical normal tissues, there has been an increased emphasis on improving the quality of life (QOL) for cancer survivors. Herein, we review the literature to examine the impact of RT on QOL and patient-reported outcomes (PROs) to better inform providers about the challenges of survivorship.

Recent Findings

Large systematic reviews, recent studies, and long-term follow-up of pivotal clinical trials have shown that RT impacts QOL, particularly fecal continence and sexual function. Modern preoperative RT techniques, which allow for decreased dose to organs-at-risk, will likely improve QOL.

Summary

RT, although critical in the treatment of rectal and anal cancer, can have a profound impact on QOL for some patients. Recent studies have included PROs and validated QOL metrics to better inform providers and patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Gilbert A, Ziegler L, Martland M, Davidson S, Efficace F, Sebag-Montefiore D, et al. Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician toxicity reporting. Int J Radiat Oncol Biol Phys. 2015;92(3):555–67.

    Article  PubMed  Google Scholar 

  2. Tom A, Bennett AV, Rothenstein D, Law E, Goodman KA. Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer. Qual Life Res. 2018;27(1):97–103.

    Article  PubMed  Google Scholar 

  3. Pieterse AH, Kunneman M, van den Hout WB, Baas-Thijssen M, Geijsen ED, Ceha HM, et al. Patient explicit consideration of tradeoffs in decision making about rectal cancer treatment: benefits for decision process and quality of life. Acta Oncol (Stockholm, Sweden). 2019:1–8.

  4. Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS, et al. Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut. 2018;67(1):179–93.

    Article  PubMed  Google Scholar 

  5. • Sodergren SC, Vassiliou V, Dennis K, Tomaszewski KA, Gilbert A, Glynne-Jones R, et al. Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy. Support Care Cancer. 2015;23(12):3613–23. An important systematic review that characterizes he common QOL complaints of anal cancer survivors and highlights the need for an anal cancer-specific-QOL questionnaire.

    Article  PubMed  Google Scholar 

  6. Fish R, Sanders C, Williamson PR, Renehan AG. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer. BMJ Open. 2017;7(11):e018726.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Fish R, Sanders C, Ryan N, der Veer SV, Renehan AG, Williamson PR. Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC). Colorectal Dis. 2018;20(5):371–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fish R, Sanders C, Adams R, Brewer J, Brookes ST, DeNardo J, et al. A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. Lancet Gastroenterol Hepatol. 2018;3(12):865–73.

    Article  PubMed  Google Scholar 

  9. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.

    Article  CAS  PubMed  Google Scholar 

  10. Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer study group on quality of life. Eur J Cancer. 1999;35(2):238–47.

    Article  CAS  PubMed  Google Scholar 

  11. Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KN, et al. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer (Oxford, England : 1990). 2007;43(10):1564–73.

    Article  CAS  Google Scholar 

  12. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the functional assessment of cancer therapy-colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999;8(3):181–95.

    Article  CAS  PubMed  Google Scholar 

  13. Sodergren SC, Johnson CD, Gilbert A, Tomaszewski KA, Chu W, Chung HT, et al. Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer. Radiother Oncol. 2018;126(2):222–8.

    Article  PubMed  Google Scholar 

  14. Sodergren SC, Gilbert A, Darlington AS, Vassiliou V. Anal cancer: putting health-related quality of life at the forefront. Clin Oncol (R Coll Radiol (Great Britain)). 2019;31(2):69–71.

    Article  CAS  Google Scholar 

  15. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77–97.

    Article  CAS  PubMed  Google Scholar 

  16. Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43(1):9–16 discussion −7.

    Article  CAS  PubMed  Google Scholar 

  17. Uwer L, Rotonda C, Guillemin F, Miny J, Kaminsky M-C, Mercier M, et al. Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes. 2011;9(1):70.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Russell MM, Ganz PA, Lopa S, Yothers G, Ko CY, Arora A, et al. Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04. Ann Surg. 2015;261(1):144–8.

    Article  PubMed  Google Scholar 

  19. Wong CKH, Chen J, Yu CLY, Sham M, Lam CLK. Systematic review recommends the European Organization for Research and Treatment of Cancer colorectal cancer–specific module for measuring quality of life in colorectal cancer patients. J Clin Epidemiol. 2015;68(3):266–78.

    Article  PubMed  Google Scholar 

  20. Bosset J, Schraub S, Pelissier E, Mercier M, Mejat E, Mantion G. Proposition of a specific quality of life scale for patients treated by conservative surgery for rectal cancer. Lyon Chir. 1993;89(1):135.

    Google Scholar 

  21. Jenkinson C, Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy. 1997;2(1):14–8.

    Article  CAS  PubMed  Google Scholar 

  22. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.

  23. Temple LK, Bacik J, Savatta SG, Gottesman L, Paty PB, Weiser MR, et al. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum. 2005;48(7):1353–65.

    Article  PubMed  Google Scholar 

  24. Cheung YB, Khoo KS, Wong ZW, See HT, Toh HC, Epstein RJ, et al. Quick-FLIC--a short questionnaire for assessing quality of life of cancer patients. Acta Oncol (Stockholm, Sweden). 2003;42(1):36–42.

    Article  Google Scholar 

  25. Cheung YB, Goh C, Wong LC, Ng GY, Lim WT, Leong SS, et al. Quick-FLIC: validation of a short questionnaire for assessing quality of life of cancer patients. Br J Cancer. 2004;90(9):1747–52.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Halkett GKB, Wigley CA, Aoun SM, Portaluri M, Tramacere F, Livi L, et al. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study. Radiat Oncol (London, England). 2018;13(162).

    Article  Google Scholar 

  27. Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(9):1847–58.

    Article  Google Scholar 

  28. • Wiltink LM, Chen TY, Nout RA, Kranenbarg EM, Fiocco M, Laurberg S, et al. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. Eur J Cancer (Oxford, England : 1990). 2014;50(14):2390–8. A 14-year follow up on patients from the Dutch TME trial shows decreases QOL in rectal cancer patients treated with neoadjuvant radiation and TME.

    Article  Google Scholar 

  29. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet (London, England). 2009;373(9666):811–20.

    Article  Google Scholar 

  30. Stephens RJ, Thompson LC, Quirke P, Steele R, Grieve R, Couture J, et al. Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada clinical trials group C016 randomized clinical trial. J Clin Oncol. 2010;28(27):4233–9.

    Article  PubMed  Google Scholar 

  31. Leon-Carlyle M, Schmocker S, Victor JC, Maier BA, O'Connor BI, Baxter NN, et al. Prevalence of physiologic sexual dysfunction is high following treatment for rectal cancer: but is it the only thing that matters? Dis Colon Rectum. 2015;58(8):736–42.

    Article  PubMed  Google Scholar 

  32. Sun V, Grant M, Wendel CS, McMullen CK, Bulkley JE, Herrinton LJ, et al. Sexual function and health-related quality of life in long-term rectal cancer survivors. J Sex Med. 2016;13(7):1071–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. • Downing A, Glaser AW, Finan PJ, Wright P, Thomas JD, Gilbert A, et al. Functional outcomes and health-related quality of life after curative treatment for rectal cancer: a population-level study in England. Int J Radiat Oncol Biol Phys. 2019;103(5):1132–42. A population-level study in England demonstrated the sexual and bowel function QOL concerns of rectal cancer patients receiving radiation therapy.

    Article  PubMed  Google Scholar 

  34. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.

    Article  CAS  PubMed  Google Scholar 

  35. Wiltink LM, Marijnen CA, Meershoek-Klein Kranenbarg E, van de Velde CJ, Nout RA. A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial. Acta Oncol (Stockholm, Sweden). 2016;55(4):502–8.

    Article  Google Scholar 

  36. Badic B, Joumond A, Thereaux J, Gancel CH, Bail JP. Long-term functional and oncological results after sphincter-saving resection for rectal cancer - cohort study. Int J Surg. 2018;52:1–6.

    Article  PubMed  Google Scholar 

  37. Hughes DL, Cornish J, Morris C. Functional outcome following rectal surgery-predisposing factors for low anterior resection syndrome. Int J Color Dis. 2017;32(5):691–7.

    Article  Google Scholar 

  38. Juul T, Ahlberg M, Biondo S, Emmertsen KJ, Espin E, Jimenez LM, et al. International validation of the low anterior resection syndrome score. Ann Surg. 2014;259(4):728–34.

    Article  PubMed  Google Scholar 

  39. Croese AD, Lonie JM, Trollope AF, Vangaveti VN, Ho YH. A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors. Int J Surg. 2018;56:234–41.

    Article  PubMed  Google Scholar 

  40. • Chen TY, Wiltink LM, Nout RA, Meershoek-Klein Kranenbarg E, Laurberg S, Marijnen CA, et al. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clin Colorectal Cancer. 2015;14(2):106–14. A multicenter randomized trial showed that neoadjuvant RT was a risk factor for major LARS and a reduced QOL.

    Article  PubMed  Google Scholar 

  41. Kupsch J, Kuhn M, Matzel KE, Zimmer J, Radulova-Mauersberger O, Sims A, et al. To what extent is the low anterior resection syndrome (LARS) associated with quality of life as measured using the EORTC C30 and CR38 quality of life questionnaires? Int J Colorectal Dis. 2019.

  42. Charlton ME, Stitzenberg KB, Lin C, Schlichting JA, Halfdanarson TR, Juarez GY, et al. Predictors of long-term quality of life for survivors of stage II/III rectal cancer in the cancer care outcomes research and surveillance consortium. J Oncol Pract. 2015;11(4):e476–86.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Boulton M, Adams E, Horne A, Durrant L, Rose P, Watson E. A qualitative study of cancer survivors' responses to information on the long-term and late effects of pelvic radiotherapy 1-11 years post treatment. Eur J Cancer Care. 2015;24(5):734–47.

    Article  CAS  Google Scholar 

  44. Battersby NJ, Juul T, Christensen P, Janjua AZ, Branagan G, Emmertsen KJ, et al. Predicting the risk of bowel-related quality-of-life impairment after restorative resection for rectal cancer: a multicenter cross-sectional study. Dis Colon Rectum. 2016;59(4):270–80.

    Article  PubMed  Google Scholar 

  45. Pietrzak L, Bujko K, Nowacki MP, Kepka L, Oledzki J, Rutkowski A, et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol. 2007;84(3):217–25.

    Article  PubMed  Google Scholar 

  46. Wiltink LM, Nout RA, van der Voort van Zyp JR, Ceha HM, Fiocco M, Meershoek-Klein Kranenbarg E, et al. Long-term health-related quality of life in patients with rectal cancer after preoperative short-course and long-course (chemo) radiotherapy. Clin Colorectal Cancer. 2016;15(3):e93–9.

    Article  PubMed  Google Scholar 

  47. Couwenberg AM, Burbach JPM, Intven MPW, Consten ECJ, Schiphorst AHW, Smits AB, et al. Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort study. Acta Oncol (Stockholm, Sweden). 2019;58(4):407–16.

    Article  Google Scholar 

  48. McLachlan SA, Fisher RJ, Zalcberg J, Solomon M, Burmeister B, Goldstein D, et al. The impact on health-related quality of life in the first 12 months: a randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04). Eur J Cancer (Oxford, England : 1990). 2016;55:15–26.

    Article  Google Scholar 

  49. Arezzo A, Arolfo S, Allaix ME, Munoz F, Cassoni P, Monagheddu C, et al. Results of neoadjuvant short-course radiation therapy followed by transanal endoscopic microsurgery for t1-t2 n0 extraperitoneal rectal cancer. Int J Radiat Oncol Biol Phys. 2015;92(2):299–306.

    Article  PubMed  Google Scholar 

  50. Creavin B, Ryan E, Martin ST, Hanly A, O'Connell PR, Sheahan K, et al. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Br J Cancer. 2017;116(2):169–74.

    Article  CAS  PubMed  Google Scholar 

  51. Allaix ME, Rebecchi F, Giaccone C, Mistrangelo M, Morino M. Long-term functional results and quality of life after transanal endoscopic microsurgery. Br J Surg. 2011;98(11):1635–43.

    Article  CAS  PubMed  Google Scholar 

  52. Perez RO, Habr-Gama A, Sao Juliao GP, Proscurshim I, Scanavini Neto A, Gama-Rodrigues J. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum. 2011;54(5):545–51.

    Article  PubMed  Google Scholar 

  53. Marks JH, Valsdottir EB, DeNittis A, Yarandi SS, Newman DA, Nweze I, et al. Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc. 2009;23(5):1081–7.

    Article  PubMed  Google Scholar 

  54. Coco C, Rizzo G, Mattana C, Gambacorta MA, Verbo A, Barbaro B, et al. Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. Surg Endosc. 2013;27(8):2860–7.

    Article  CAS  PubMed  Google Scholar 

  55. Gornicki A, Richter P, Polkowski W, Szczepkowski M, Pietrzak L, Kepka L, et al. Anorectal and sexual functions after preoperative radiotherapy and full-thickness local excision of rectal cancer. Eur J Surg Oncol (EJSO). 2014;40(6):723–30.

    Article  CAS  Google Scholar 

  56. • Lynn PB, Renfro LA, Carrero XW, Shi Q, Strombom PL, Chow O, et al. Anorectal function and quality of life in patients with early stage rectal cancer treated with chemoradiation and local excision. Dis Colon Rectum. 2017;60(5):459–68. A single-arm, phase II study shows that neoadjuvant chemoradiotherapy and local excision is a viable organ-preserving strategy in patients with T2N0 rectal cancer.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Honda M, Akiyoshi T, Noma H, Ogura A, Nagasaki T, Konishi T, et al. Patient-centered outcomes to decide treatment strategy for patients with low rectal cancer. J Surg Oncol. 2016;114(5):630–6.

    Article  CAS  PubMed  Google Scholar 

  58. Saito N, Ito M, Kobayashi A, Nishizawa Y, Kojima M, Nishizawa Y, et al. Long-term outcomes after intersphincteric resection for low-lying rectal cancer. Ann Surg Oncol. 2014;21(11):3608–15.

    Article  PubMed  Google Scholar 

  59. Ghiselli R, Ortenzi M, Cardinali L, Skrami E, Gesuita R, Guerrieri M. Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy. Surg Endosc. 2017;31(7):2997–3003.

    Article  PubMed  Google Scholar 

  60. Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16(15):1537–46.

    Article  PubMed  PubMed Central  Google Scholar 

  61. • Stijns RCH, de Graaf EJR, Punt CJA, Nagtegaal ID, Nuyttens J, van Meerten E, et al. Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study. JAMA Surg. 2019;154(1):47–54. A phase II study shows that CRT and TEM enables organ preservation and good QOL outcomes, with a risk of bowel dysfunction and overtreatment.

    Article  PubMed  Google Scholar 

  62. Borstlap WA, Tanis PJ, Koedam TW, Marijnen CA, Cunningham C, Dekker E, et al. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer. 2016;16:513.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, et al. Can we save the rectum by watchful waiting or transanal microsurgery following (chemo) radiotherapy versus total mesorectal excision for early rectal cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open. 2017;7(12):e019474.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Habr-Gama A, Lynn PB, Jorge JM, Sao Juliao GP, Proscurshim I, Gama-Rodrigues J, et al. Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation. Dis Colon Rectum. 2016;59(4):264–9.

    Article  PubMed  Google Scholar 

  65. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–7 discussion 7-8.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Hupkens BJP, Martens MH, Stoot JH, Berbee M, Melenhorst J, Beets-Tan RG, et al. Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection - a matched-controlled study. Dis Colon Rectum. 2017;60(10):1032–40.

    Article  PubMed  Google Scholar 

  67. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet (London, England). 1996;348(9034):1049–54.

  68. Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR anal cancer trial (ACT I). Br J Cancer. 2010;102(7):1123–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Tournier-Rangeard L, Mercier M, Peiffert D, Gerard JP, Romestaing P, Lemanski C, et al. Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol. 2008;87(3):391–7.

    Article  CAS  PubMed  Google Scholar 

  70. Bentzen AG, Balteskard L, Wanderas EH, Frykholm G, Wilsgaard T, Dahl O, et al. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol (Stockholm, Sweden). 2013;52(4):736–44.

    Article  Google Scholar 

  71. Koerber SA, Slynko A, Haefner MF, Krug D, Schoneweg C, Kessel K, et al. Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis. Radiat Oncol (London, England). 2014;9:113.

    Article  Google Scholar 

  72. Koerber SA, Seither B, Slynko A, Haefner MF, Krug D, Liermann J, et al. Chemoradiation in female patients with anal cancer: patient-reported outcome of acute and chronic side effects. Tumori. 2019;105(2):174–80.

    Article  PubMed  Google Scholar 

  73. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

    Article  PubMed  Google Scholar 

  74. Joseph K, Vos LJ, Warkentin H, Paulson K, Polkosnik LA, Usmani N, et al. Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer. Radiother Oncol. 2016;120(2):228–33.

    Article  PubMed  Google Scholar 

  75. Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, et al. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer. Int J Radiat Oncol Biol Phys. 2014;90(3):587–94.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA

    Shane S. Neibart & Salma K. Jabbour

  2. Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA

    Sharon L. Manne

Authors
  1. Shane S. Neibart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon L. Manne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salma K. Jabbour
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salma K. Jabbour.

Ethics declarations

Conflict of Interest

Shane S. Neibart, Sharon L. Manne, and Salma K. Jabbour each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Radiation Therapy and Radiation Therapy Innovations in Colorectal Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neibart, S.S., Manne, S.L. & Jabbour, S.K. Quality of Life After Radiotherapy for Rectal and Anal Cancer. Curr Colorectal Cancer Rep 16, 1–10 (2020). https://doi.org/10.1007/s11888-019-00448-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-019-00448-w

Keywords

Search

Navigation